nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CYP3A4—type 2 diabetes mellitus	0.0885	0.351	CbGaD
Celecoxib—PTGS2—type 2 diabetes mellitus	0.0867	0.343	CbGaD
Celecoxib—ALB—type 2 diabetes mellitus	0.0772	0.306	CbGaD
Celecoxib—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0427	0.1	CbGbCtD
Celecoxib—ORM1—Nateglinide—type 2 diabetes mellitus	0.0376	0.0885	CbGbCtD
Celecoxib—ALB—Gliclazide—type 2 diabetes mellitus	0.0246	0.0578	CbGbCtD
Celecoxib—ALB—Repaglinide—type 2 diabetes mellitus	0.0231	0.0543	CbGbCtD
Celecoxib—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0193	0.0453	CbGbCtD
Celecoxib—ALB—Valsartan—type 2 diabetes mellitus	0.017	0.04	CbGbCtD
Celecoxib—ALB—Nateglinide—type 2 diabetes mellitus	0.0158	0.0372	CbGbCtD
Celecoxib—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0156	0.0366	CbGbCtD
Celecoxib—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0143	0.0335	CbGbCtD
Celecoxib—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0132	0.0311	CbGbCtD
Celecoxib—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0113	0.0265	CbGbCtD
Celecoxib—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0113	0.0265	CbGbCtD
Celecoxib—ALB—Glyburide—type 2 diabetes mellitus	0.0107	0.0251	CbGbCtD
Celecoxib—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0104	0.0244	CbGbCtD
Celecoxib—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0242	CbGbCtD
Celecoxib—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0102	0.0239	CbGbCtD
Celecoxib—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.01	0.0236	CbGbCtD
Celecoxib—ALB—Losartan—type 2 diabetes mellitus	0.00979	0.023	CbGbCtD
Celecoxib—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00951	0.0223	CbGbCtD
Celecoxib—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00918	0.0216	CbGbCtD
Celecoxib—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00906	0.0213	CbGbCtD
Celecoxib—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00854	0.0201	CbGbCtD
Celecoxib—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00829	0.0195	CbGbCtD
Celecoxib—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00818	0.0192	CbGbCtD
Celecoxib—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00781	0.0183	CbGbCtD
Celecoxib—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00748	0.0176	CbGbCtD
Celecoxib—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00724	0.017	CbGbCtD
Celecoxib—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00655	0.0154	CbGbCtD
Celecoxib—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00577	0.0136	CbGbCtD
Celecoxib—CYP2C9—Losartan—type 2 diabetes mellitus	0.00527	0.0124	CbGbCtD
Celecoxib—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00496	0.0117	CbGbCtD
Celecoxib—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00476	0.0112	CbGbCtD
Celecoxib—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00476	0.0112	CbGbCtD
Celecoxib—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0045	0.0106	CbGbCtD
Celecoxib—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00335	0.00788	CbGbCtD
Celecoxib—CYP3A4—Losartan—type 2 diabetes mellitus	0.00307	0.00721	CbGbCtD
Celecoxib—PDPK1—retina—type 2 diabetes mellitus	0.00174	0.0598	CbGeAlD
Celecoxib—PDPK1—nephron tubule—type 2 diabetes mellitus	0.00164	0.0563	CbGeAlD
Celecoxib—PDPK1—kidney—type 2 diabetes mellitus	0.00144	0.0495	CbGeAlD
Celecoxib—PDPK1—adipose tissue—type 2 diabetes mellitus	0.0013	0.0446	CbGeAlD
Celecoxib—PTGS2—leg—type 2 diabetes mellitus	0.00119	0.0409	CbGeAlD
Celecoxib—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00111	0.0384	CbGeAlD
Celecoxib—PTGS2—hindlimb—type 2 diabetes mellitus	0.00106	0.0365	CbGeAlD
Celecoxib—CA4—nerve—type 2 diabetes mellitus	0.00105	0.0363	CbGeAlD
Celecoxib—PDPK1—liver—type 2 diabetes mellitus	0.000908	0.0313	CbGeAlD
Celecoxib—CA5A—liver—type 2 diabetes mellitus	0.000853	0.0294	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—type 2 diabetes mellitus	0.000785	0.0271	CbGeAlD
Celecoxib—MAPK14—kidney—type 2 diabetes mellitus	0.000769	0.0265	CbGeAlD
Celecoxib—Etoricoxib—CYP2E1—type 2 diabetes mellitus	0.000734	0.313	CrCbGaD
Celecoxib—Etoricoxib—CYP1A2—type 2 diabetes mellitus	0.000699	0.298	CrCbGaD
Celecoxib—MAPK14—adipose tissue—type 2 diabetes mellitus	0.000693	0.0239	CbGeAlD
Celecoxib—PTGS2—artery—type 2 diabetes mellitus	0.00065	0.0224	CbGeAlD
Celecoxib—CA12—kidney—type 2 diabetes mellitus	0.000583	0.0201	CbGeAlD
Celecoxib—PTGS2—endothelium—type 2 diabetes mellitus	0.000549	0.0189	CbGeAlD
Celecoxib—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000535	0.0184	CbGeAlD
Celecoxib—CA5B—pancreas—type 2 diabetes mellitus	0.00052	0.0179	CbGeAlD
Celecoxib—CA4—islet of Langerhans—type 2 diabetes mellitus	0.00051	0.0176	CbGeAlD
Celecoxib—MAPK14—liver—type 2 diabetes mellitus	0.000486	0.0167	CbGeAlD
Celecoxib—CA14—liver—type 2 diabetes mellitus	0.000473	0.0163	CbGeAlD
Celecoxib—CA5B—adipose tissue—type 2 diabetes mellitus	0.000471	0.0162	CbGeAlD
Celecoxib—Etoricoxib—CYP3A4—type 2 diabetes mellitus	0.000462	0.197	CrCbGaD
Celecoxib—Etoricoxib—PTGS2—type 2 diabetes mellitus	0.000453	0.193	CrCbGaD
Celecoxib—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000447	0.0154	CbGeAlD
Celecoxib—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000423	0.0146	CbGeAlD
Celecoxib—CA4—nephron tubule—type 2 diabetes mellitus	0.000411	0.0142	CbGeAlD
Celecoxib—ABCC4—kidney—type 2 diabetes mellitus	0.000393	0.0135	CbGeAlD
Celecoxib—ABCC4—pancreas—type 2 diabetes mellitus	0.00039	0.0134	CbGeAlD
Celecoxib—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000382	0.0132	CbGeAlD
Celecoxib—CA4—cardiovascular system—type 2 diabetes mellitus	0.000369	0.0127	CbGeAlD
Celecoxib—CA2—retina—type 2 diabetes mellitus	0.000362	0.0125	CbGeAlD
Celecoxib—CA4—kidney—type 2 diabetes mellitus	0.000361	0.0124	CbGeAlD
Celecoxib—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000354	0.0122	CbGeAlD
Celecoxib—CA4—cortex of kidney—type 2 diabetes mellitus	0.000352	0.0121	CbGeAlD
Celecoxib—CA2—nephron tubule—type 2 diabetes mellitus	0.000341	0.0117	CbGeAlD
Celecoxib—CA4—adipose tissue—type 2 diabetes mellitus	0.000325	0.0112	CbGeAlD
Celecoxib—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000312	0.0108	CbGeAlD
Celecoxib—CA2—cardiovascular system—type 2 diabetes mellitus	0.000306	0.0105	CbGeAlD
Celecoxib—CA2—kidney—type 2 diabetes mellitus	0.000299	0.0103	CbGeAlD
Celecoxib—CA2—pancreas—type 2 diabetes mellitus	0.000297	0.0102	CbGeAlD
Celecoxib—ORM1—liver—type 2 diabetes mellitus	0.000292	0.0101	CbGeAlD
Celecoxib—CA2—cortex of kidney—type 2 diabetes mellitus	0.000292	0.01	CbGeAlD
Celecoxib—CA2—adipose tissue—type 2 diabetes mellitus	0.00027	0.0093	CbGeAlD
Celecoxib—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000259	0.00892	CbGeAlD
Celecoxib—ALB—liver—type 2 diabetes mellitus	0.000256	0.00884	CbGeAlD
Celecoxib—ABCC4—liver—type 2 diabetes mellitus	0.000248	0.00855	CbGeAlD
Celecoxib—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000226	0.00778	CbGeAlD
Celecoxib—PTGS2—kidney—type 2 diabetes mellitus	0.000221	0.00761	CbGeAlD
Celecoxib—PTGS2—pancreas—type 2 diabetes mellitus	0.00022	0.00756	CbGeAlD
Celecoxib—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000199	0.00686	CbGeAlD
Celecoxib—CYP3A4—kidney—type 2 diabetes mellitus	0.000193	0.00665	CbGeAlD
Celecoxib—CYP2D6—kidney—type 2 diabetes mellitus	0.00019	0.00655	CbGeAlD
Celecoxib—CA2—liver—type 2 diabetes mellitus	0.000189	0.00652	CbGeAlD
Celecoxib—CYP2C9—liver—type 2 diabetes mellitus	0.00016	0.00552	CbGeAlD
Celecoxib—PTGS2—liver—type 2 diabetes mellitus	0.00014	0.00481	CbGeAlD
Celecoxib—CYP3A4—liver—type 2 diabetes mellitus	0.000122	0.00421	CbGeAlD
Celecoxib—CYP2D6—liver—type 2 diabetes mellitus	0.00012	0.00414	CbGeAlD
Celecoxib—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.37e-05	0.000309	CcSEcCtD
Celecoxib—Flushing—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000309	CcSEcCtD
Celecoxib—Angioedema—Losartan—type 2 diabetes mellitus	5.36e-05	0.000308	CcSEcCtD
Celecoxib—Infection—Metformin—type 2 diabetes mellitus	5.36e-05	0.000308	CcSEcCtD
Celecoxib—Insomnia—Valsartan—type 2 diabetes mellitus	5.36e-05	0.000308	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000307	CcSEcCtD
Celecoxib—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.32e-05	0.000306	CcSEcCtD
Celecoxib—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000305	CcSEcCtD
Celecoxib—Chest pain—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000305	CcSEcCtD
Celecoxib—Myalgia—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000305	CcSEcCtD
Celecoxib—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000305	CcSEcCtD
Celecoxib—Shock—Metformin—type 2 diabetes mellitus	5.31e-05	0.000305	CcSEcCtD
Celecoxib—Insomnia—Orlistat—type 2 diabetes mellitus	5.29e-05	0.000304	CcSEcCtD
Celecoxib—Anxiety—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000304	CcSEcCtD
Celecoxib—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.29e-05	0.000304	CcSEcCtD
Celecoxib—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.29e-05	0.000304	CcSEcCtD
Celecoxib—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.28e-05	0.000304	CcSEcCtD
Celecoxib—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.28e-05	0.000304	CcSEcCtD
Celecoxib—Vertigo—Losartan—type 2 diabetes mellitus	5.27e-05	0.000303	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000303	CcSEcCtD
Celecoxib—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.27e-05	0.000303	CcSEcCtD
Celecoxib—Somnolence—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000303	CcSEcCtD
Celecoxib—Syncope—Losartan—type 2 diabetes mellitus	5.26e-05	0.000303	CcSEcCtD
Celecoxib—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.26e-05	0.000302	CcSEcCtD
Celecoxib—Leukopenia—Losartan—type 2 diabetes mellitus	5.25e-05	0.000302	CcSEcCtD
Celecoxib—Skin disorder—Metformin—type 2 diabetes mellitus	5.24e-05	0.000301	CcSEcCtD
Celecoxib—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.22e-05	0.0003	CcSEcCtD
Celecoxib—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.21e-05	0.0003	CcSEcCtD
Celecoxib—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.21e-05	0.0003	CcSEcCtD
Celecoxib—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.21e-05	0.0003	CcSEcCtD
Celecoxib—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.19e-05	0.000299	CcSEcCtD
Celecoxib—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000299	CcSEcCtD
Celecoxib—Palpitations—Losartan—type 2 diabetes mellitus	5.19e-05	0.000298	CcSEcCtD
Celecoxib—Nausea—Glimepiride—type 2 diabetes mellitus	5.17e-05	0.000297	CcSEcCtD
Celecoxib—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000297	CcSEcCtD
Celecoxib—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.16e-05	0.000297	CcSEcCtD
Celecoxib—Nausea—Sitagliptin—type 2 diabetes mellitus	5.15e-05	0.000296	CcSEcCtD
Celecoxib—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.15e-05	0.000296	CcSEcCtD
Celecoxib—Asthenia—Glyburide—type 2 diabetes mellitus	5.15e-05	0.000296	CcSEcCtD
Celecoxib—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000296	CcSEcCtD
Celecoxib—Anorexia—Metformin—type 2 diabetes mellitus	5.14e-05	0.000296	CcSEcCtD
Celecoxib—Cough—Losartan—type 2 diabetes mellitus	5.12e-05	0.000295	CcSEcCtD
Celecoxib—Urticaria—Gliclazide—type 2 diabetes mellitus	5.12e-05	0.000295	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000294	CcSEcCtD
Celecoxib—Alopecia—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000294	CcSEcCtD
Celecoxib—Fatigue—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000294	CcSEcCtD
Celecoxib—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.1e-05	0.000293	CcSEcCtD
Celecoxib—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.1e-05	0.000293	CcSEcCtD
Celecoxib—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000293	CcSEcCtD
Celecoxib—Oedema—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000293	CcSEcCtD
Celecoxib—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000293	CcSEcCtD
Celecoxib—Pruritus—Glyburide—type 2 diabetes mellitus	5.08e-05	0.000292	CcSEcCtD
Celecoxib—Mental disorder—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000291	CcSEcCtD
Celecoxib—Constipation—Valsartan—type 2 diabetes mellitus	5.06e-05	0.000291	CcSEcCtD
Celecoxib—Infection—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000291	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000291	CcSEcCtD
Celecoxib—Fatigue—Orlistat—type 2 diabetes mellitus	5.05e-05	0.00029	CcSEcCtD
Celecoxib—Shock—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000288	CcSEcCtD
Celecoxib—Myalgia—Losartan—type 2 diabetes mellitus	5e-05	0.000287	CcSEcCtD
Celecoxib—Arthralgia—Losartan—type 2 diabetes mellitus	5e-05	0.000287	CcSEcCtD
Celecoxib—Chest pain—Losartan—type 2 diabetes mellitus	5e-05	0.000287	CcSEcCtD
Celecoxib—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.99e-05	0.000287	CcSEcCtD
Celecoxib—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.000287	CcSEcCtD
Celecoxib—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000287	CcSEcCtD
Celecoxib—Anxiety—Losartan—type 2 diabetes mellitus	4.98e-05	0.000286	CcSEcCtD
Celecoxib—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.97e-05	0.000286	CcSEcCtD
Celecoxib—Rash—Bromocriptine—type 2 diabetes mellitus	4.95e-05	0.000285	CcSEcCtD
Celecoxib—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.95e-05	0.000284	CcSEcCtD
Celecoxib—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000284	CcSEcCtD
Celecoxib—Tension—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000284	CcSEcCtD
Celecoxib—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000283	CcSEcCtD
Celecoxib—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000283	CcSEcCtD
Celecoxib—Headache—Bromocriptine—type 2 diabetes mellitus	4.92e-05	0.000283	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.91e-05	0.000283	CcSEcCtD
Celecoxib—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.91e-05	0.000282	CcSEcCtD
Celecoxib—Nervousness—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000281	CcSEcCtD
Celecoxib—Dry mouth—Losartan—type 2 diabetes mellitus	4.89e-05	0.000281	CcSEcCtD
Celecoxib—Anorexia—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000279	CcSEcCtD
Celecoxib—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.84e-05	0.000279	CcSEcCtD
Celecoxib—Paraesthesia—Metformin—type 2 diabetes mellitus	4.84e-05	0.000279	CcSEcCtD
Celecoxib—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000278	CcSEcCtD
Celecoxib—Confusional state—Losartan—type 2 diabetes mellitus	4.83e-05	0.000278	CcSEcCtD
Celecoxib—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000277	CcSEcCtD
Celecoxib—Dyspnoea—Metformin—type 2 diabetes mellitus	4.81e-05	0.000277	CcSEcCtD
Celecoxib—Somnolence—Metformin—type 2 diabetes mellitus	4.8e-05	0.000276	CcSEcCtD
Celecoxib—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.79e-05	0.000275	CcSEcCtD
Celecoxib—Oedema—Losartan—type 2 diabetes mellitus	4.79e-05	0.000275	CcSEcCtD
Celecoxib—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.79e-05	0.000275	CcSEcCtD
Celecoxib—Infection—Losartan—type 2 diabetes mellitus	4.76e-05	0.000274	CcSEcCtD
Celecoxib—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.75e-05	0.000273	CcSEcCtD
Celecoxib—Dyspepsia—Metformin—type 2 diabetes mellitus	4.75e-05	0.000273	CcSEcCtD
Celecoxib—Shock—Losartan—type 2 diabetes mellitus	4.71e-05	0.000271	CcSEcCtD
Celecoxib—Urticaria—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000271	CcSEcCtD
Celecoxib—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.7e-05	0.00027	CcSEcCtD
Celecoxib—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.69e-05	0.00027	CcSEcCtD
Celecoxib—Decreased appetite—Metformin—type 2 diabetes mellitus	4.69e-05	0.00027	CcSEcCtD
Celecoxib—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.68e-05	0.000269	CcSEcCtD
Celecoxib—Tachycardia—Losartan—type 2 diabetes mellitus	4.68e-05	0.000269	CcSEcCtD
Celecoxib—Nausea—Bromocriptine—type 2 diabetes mellitus	4.66e-05	0.000268	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.66e-05	0.000268	CcSEcCtD
Celecoxib—Fatigue—Metformin—type 2 diabetes mellitus	4.65e-05	0.000267	CcSEcCtD
Celecoxib—Urticaria—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000267	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.000267	CcSEcCtD
Celecoxib—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.63e-05	0.000266	CcSEcCtD
Celecoxib—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000266	CcSEcCtD
Celecoxib—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.63e-05	0.000266	CcSEcCtD
Celecoxib—Asthenia—Gliclazide—type 2 diabetes mellitus	4.63e-05	0.000266	CcSEcCtD
Celecoxib—Constipation—Metformin—type 2 diabetes mellitus	4.61e-05	0.000265	CcSEcCtD
Celecoxib—Angioedema—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000264	CcSEcCtD
Celecoxib—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000263	CcSEcCtD
Celecoxib—Anorexia—Losartan—type 2 diabetes mellitus	4.57e-05	0.000263	CcSEcCtD
Celecoxib—Vomiting—Glyburide—type 2 diabetes mellitus	4.56e-05	0.000263	CcSEcCtD
Celecoxib—Pruritus—Gliclazide—type 2 diabetes mellitus	4.56e-05	0.000262	CcSEcCtD
Celecoxib—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000261	CcSEcCtD
Celecoxib—Rash—Glyburide—type 2 diabetes mellitus	4.53e-05	0.00026	CcSEcCtD
Celecoxib—Somnolence—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.00026	CcSEcCtD
Celecoxib—Dermatitis—Glyburide—type 2 diabetes mellitus	4.52e-05	0.00026	CcSEcCtD
Celecoxib—Vertigo—Ramipril—type 2 diabetes mellitus	4.52e-05	0.00026	CcSEcCtD
Celecoxib—Syncope—Ramipril—type 2 diabetes mellitus	4.51e-05	0.00026	CcSEcCtD
Celecoxib—Leukopenia—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000259	CcSEcCtD
Celecoxib—Headache—Glyburide—type 2 diabetes mellitus	4.5e-05	0.000259	CcSEcCtD
Celecoxib—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.48e-05	0.000258	CcSEcCtD
Celecoxib—Palpitations—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000256	CcSEcCtD
Celecoxib—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.44e-05	0.000256	CcSEcCtD
Celecoxib—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000254	CcSEcCtD
Celecoxib—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000254	CcSEcCtD
Celecoxib—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.41e-05	0.000254	CcSEcCtD
Celecoxib—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.41e-05	0.000254	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000253	CcSEcCtD
Celecoxib—Cough—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000253	CcSEcCtD
Celecoxib—Fatigue—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000252	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.36e-05	0.000251	CcSEcCtD
Celecoxib—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.36e-05	0.000251	CcSEcCtD
Celecoxib—Constipation—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.00025	CcSEcCtD
Celecoxib—Insomnia—Losartan—type 2 diabetes mellitus	4.33e-05	0.000249	CcSEcCtD
Celecoxib—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.31e-05	0.000248	CcSEcCtD
Celecoxib—Paraesthesia—Losartan—type 2 diabetes mellitus	4.3e-05	0.000247	CcSEcCtD
Celecoxib—Urticaria—Metformin—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Celecoxib—Arthralgia—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Celecoxib—Chest pain—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Celecoxib—Myalgia—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Celecoxib—Dyspnoea—Losartan—type 2 diabetes mellitus	4.27e-05	0.000246	CcSEcCtD
Celecoxib—Anxiety—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000246	CcSEcCtD
Celecoxib—Nausea—Glyburide—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Celecoxib—Abdominal pain—Metformin—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Celecoxib—Dizziness—Gliclazide—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Celecoxib—Somnolence—Losartan—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Celecoxib—Asthenia—Valsartan—type 2 diabetes mellitus	4.25e-05	0.000244	CcSEcCtD
Celecoxib—Dyspepsia—Losartan—type 2 diabetes mellitus	4.22e-05	0.000242	CcSEcCtD
Celecoxib—Asthenia—Orlistat—type 2 diabetes mellitus	4.2e-05	0.000241	CcSEcCtD
Celecoxib—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000241	CcSEcCtD
Celecoxib—Pruritus—Valsartan—type 2 diabetes mellitus	4.19e-05	0.000241	CcSEcCtD
Celecoxib—Dry mouth—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000241	CcSEcCtD
Celecoxib—Decreased appetite—Losartan—type 2 diabetes mellitus	4.16e-05	0.000239	CcSEcCtD
Celecoxib—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.16e-05	0.000239	CcSEcCtD
Celecoxib—Confusional state—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000238	CcSEcCtD
Celecoxib—Pruritus—Orlistat—type 2 diabetes mellitus	4.14e-05	0.000238	CcSEcCtD
Celecoxib—Fatigue—Losartan—type 2 diabetes mellitus	4.13e-05	0.000237	CcSEcCtD
Celecoxib—Oedema—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000236	CcSEcCtD
Celecoxib—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000236	CcSEcCtD
Celecoxib—Vomiting—Gliclazide—type 2 diabetes mellitus	4.1e-05	0.000236	CcSEcCtD
Celecoxib—Constipation—Losartan—type 2 diabetes mellitus	4.1e-05	0.000236	CcSEcCtD
Celecoxib—Rash—Gliclazide—type 2 diabetes mellitus	4.06e-05	0.000234	CcSEcCtD
Celecoxib—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.06e-05	0.000234	CcSEcCtD
Celecoxib—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.05e-05	0.000233	CcSEcCtD
Celecoxib—Urticaria—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000233	CcSEcCtD
Celecoxib—Shock—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000232	CcSEcCtD
Celecoxib—Headache—Gliclazide—type 2 diabetes mellitus	4.04e-05	0.000232	CcSEcCtD
Celecoxib—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000232	CcSEcCtD
Celecoxib—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000231	CcSEcCtD
Celecoxib—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000231	CcSEcCtD
Celecoxib—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000231	CcSEcCtD
Celecoxib—Tachycardia—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000231	CcSEcCtD
Celecoxib—Diarrhoea—Orlistat—type 2 diabetes mellitus	4e-05	0.00023	CcSEcCtD
Celecoxib—Skin disorder—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000229	CcSEcCtD
Celecoxib—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000228	CcSEcCtD
Celecoxib—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.95e-05	0.000227	CcSEcCtD
Celecoxib—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.92e-05	0.000225	CcSEcCtD
Celecoxib—Dizziness—Valsartan—type 2 diabetes mellitus	3.92e-05	0.000225	CcSEcCtD
Celecoxib—Anorexia—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000225	CcSEcCtD
Celecoxib—Dizziness—Orlistat—type 2 diabetes mellitus	3.87e-05	0.000223	CcSEcCtD
Celecoxib—Asthenia—Metformin—type 2 diabetes mellitus	3.87e-05	0.000223	CcSEcCtD
Celecoxib—Nausea—Gliclazide—type 2 diabetes mellitus	3.83e-05	0.00022	CcSEcCtD
Celecoxib—Pruritus—Metformin—type 2 diabetes mellitus	3.82e-05	0.000219	CcSEcCtD
Celecoxib—Urticaria—Losartan—type 2 diabetes mellitus	3.81e-05	0.000219	CcSEcCtD
Celecoxib—Abdominal pain—Losartan—type 2 diabetes mellitus	3.79e-05	0.000218	CcSEcCtD
Celecoxib—Body temperature increased—Losartan—type 2 diabetes mellitus	3.79e-05	0.000218	CcSEcCtD
Celecoxib—Vomiting—Valsartan—type 2 diabetes mellitus	3.77e-05	0.000217	CcSEcCtD
Celecoxib—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000216	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000215	CcSEcCtD
Celecoxib—Rash—Valsartan—type 2 diabetes mellitus	3.73e-05	0.000215	CcSEcCtD
Celecoxib—Dermatitis—Valsartan—type 2 diabetes mellitus	3.73e-05	0.000215	CcSEcCtD
Celecoxib—Vomiting—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000214	CcSEcCtD
Celecoxib—Insomnia—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000214	CcSEcCtD
Celecoxib—Headache—Valsartan—type 2 diabetes mellitus	3.71e-05	0.000213	CcSEcCtD
Celecoxib—Diarrhoea—Metformin—type 2 diabetes mellitus	3.69e-05	0.000212	CcSEcCtD
Celecoxib—Rash—Orlistat—type 2 diabetes mellitus	3.69e-05	0.000212	CcSEcCtD
Celecoxib—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000212	CcSEcCtD
Celecoxib—Dermatitis—Orlistat—type 2 diabetes mellitus	3.69e-05	0.000212	CcSEcCtD
Celecoxib—Headache—Orlistat—type 2 diabetes mellitus	3.67e-05	0.000211	CcSEcCtD
Celecoxib—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000211	CcSEcCtD
Celecoxib—Asthenia—Irbesartan—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Celecoxib—Somnolence—Ramipril—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Celecoxib—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000208	CcSEcCtD
Celecoxib—Pruritus—Irbesartan—type 2 diabetes mellitus	3.6e-05	0.000207	CcSEcCtD
Celecoxib—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000205	CcSEcCtD
Celecoxib—Dizziness—Metformin—type 2 diabetes mellitus	3.57e-05	0.000205	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000204	CcSEcCtD
Celecoxib—Fatigue—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000204	CcSEcCtD
Celecoxib—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.53e-05	0.000203	CcSEcCtD
Celecoxib—Nausea—Valsartan—type 2 diabetes mellitus	3.52e-05	0.000202	CcSEcCtD
Celecoxib—Constipation—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000202	CcSEcCtD
Celecoxib—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.0002	CcSEcCtD
Celecoxib—Nausea—Orlistat—type 2 diabetes mellitus	3.48e-05	0.0002	CcSEcCtD
Celecoxib—Asthenia—Losartan—type 2 diabetes mellitus	3.44e-05	0.000198	CcSEcCtD
Celecoxib—Vomiting—Metformin—type 2 diabetes mellitus	3.43e-05	0.000197	CcSEcCtD
Celecoxib—Rash—Metformin—type 2 diabetes mellitus	3.4e-05	0.000196	CcSEcCtD
Celecoxib—Dermatitis—Metformin—type 2 diabetes mellitus	3.4e-05	0.000195	CcSEcCtD
Celecoxib—Pruritus—Losartan—type 2 diabetes mellitus	3.39e-05	0.000195	CcSEcCtD
Celecoxib—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000195	CcSEcCtD
Celecoxib—Headache—Metformin—type 2 diabetes mellitus	3.38e-05	0.000194	CcSEcCtD
Celecoxib—Dizziness—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000194	CcSEcCtD
Celecoxib—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.36e-05	0.000193	CcSEcCtD
Celecoxib—Diarrhoea—Losartan—type 2 diabetes mellitus	3.28e-05	0.000188	CcSEcCtD
Celecoxib—Urticaria—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000188	CcSEcCtD
Celecoxib—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000187	CcSEcCtD
Celecoxib—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000187	CcSEcCtD
Celecoxib—Vomiting—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000186	CcSEcCtD
Celecoxib—Rash—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000185	CcSEcCtD
Celecoxib—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000184	CcSEcCtD
Celecoxib—Nausea—Metformin—type 2 diabetes mellitus	3.2e-05	0.000184	CcSEcCtD
Celecoxib—Headache—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000183	CcSEcCtD
Celecoxib—Dizziness—Losartan—type 2 diabetes mellitus	3.17e-05	0.000182	CcSEcCtD
Celecoxib—Vomiting—Losartan—type 2 diabetes mellitus	3.05e-05	0.000175	CcSEcCtD
Celecoxib—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000174	CcSEcCtD
Celecoxib—Nausea—Irbesartan—type 2 diabetes mellitus	3.02e-05	0.000174	CcSEcCtD
Celecoxib—Rash—Losartan—type 2 diabetes mellitus	3.02e-05	0.000174	CcSEcCtD
Celecoxib—Dermatitis—Losartan—type 2 diabetes mellitus	3.02e-05	0.000174	CcSEcCtD
Celecoxib—Headache—Losartan—type 2 diabetes mellitus	3e-05	0.000173	CcSEcCtD
Celecoxib—Asthenia—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000169	CcSEcCtD
Celecoxib—Pruritus—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000167	CcSEcCtD
Celecoxib—Nausea—Losartan—type 2 diabetes mellitus	2.85e-05	0.000164	CcSEcCtD
Celecoxib—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000162	CcSEcCtD
Celecoxib—Dizziness—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000156	CcSEcCtD
Celecoxib—Vomiting—Ramipril—type 2 diabetes mellitus	2.61e-05	0.00015	CcSEcCtD
Celecoxib—Rash—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000149	CcSEcCtD
Celecoxib—Dermatitis—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000149	CcSEcCtD
Celecoxib—Headache—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000148	CcSEcCtD
Celecoxib—Nausea—Ramipril—type 2 diabetes mellitus	2.44e-05	0.00014	CcSEcCtD
Celecoxib—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.87e-06	2.46e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	2.87e-06	2.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—type 2 diabetes mellitus	2.87e-06	2.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.87e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	2.87e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	2.87e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	2.87e-06	2.45e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.86e-06	2.45e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	2.85e-06	2.44e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.85e-06	2.44e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	2.85e-06	2.44e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	2.84e-06	2.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	2.84e-06	2.43e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	2.84e-06	2.43e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.82e-06	2.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.8e-06	2.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.8e-06	2.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.8e-06	2.4e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.8e-06	2.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.79e-06	2.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	2.77e-06	2.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	2.77e-06	2.37e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	2.76e-06	2.37e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.76e-06	2.36e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.76e-06	2.36e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—type 2 diabetes mellitus	2.74e-06	2.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.73e-06	2.34e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	2.72e-06	2.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GCG—type 2 diabetes mellitus	2.72e-06	2.33e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.71e-06	2.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	2.71e-06	2.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS2—type 2 diabetes mellitus	2.7e-06	2.31e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	2.69e-06	2.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKB1—type 2 diabetes mellitus	2.66e-06	2.28e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALM1—type 2 diabetes mellitus	2.65e-06	2.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—type 2 diabetes mellitus	2.65e-06	2.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—type 2 diabetes mellitus	2.64e-06	2.26e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	2.64e-06	2.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.63e-06	2.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOA1—type 2 diabetes mellitus	2.61e-06	2.24e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.59e-06	2.22e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.59e-06	2.22e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.59e-06	2.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	2.59e-06	2.21e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.58e-06	2.21e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.58e-06	2.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	2.58e-06	2.21e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	2.57e-06	2.2e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	2.57e-06	2.2e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	2.57e-06	2.2e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.55e-06	2.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	2.52e-06	2.16e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.52e-06	2.16e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	2.51e-06	2.15e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	2.5e-06	2.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SRC—type 2 diabetes mellitus	2.48e-06	2.13e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.48e-06	2.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—type 2 diabetes mellitus	2.48e-06	2.12e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.47e-06	2.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.47e-06	2.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.46e-06	2.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—type 2 diabetes mellitus	2.46e-06	2.11e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SRC—type 2 diabetes mellitus	2.45e-06	2.1e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—type 2 diabetes mellitus	2.45e-06	2.1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	2.45e-06	2.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.44e-06	2.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.39e-06	2.05e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.39e-06	2.05e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	2.38e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.38e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.38e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.38e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.38e-06	2.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	2.38e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.37e-06	2.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS1—type 2 diabetes mellitus	2.36e-06	2.02e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.35e-06	2.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNB3—type 2 diabetes mellitus	2.35e-06	2.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.35e-06	2.01e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-06	2.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.34e-06	2.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.34e-06	2.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	2.34e-06	2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	2.33e-06	2e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.32e-06	1.99e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.32e-06	1.99e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAT—type 2 diabetes mellitus	2.3e-06	1.97e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.29e-06	1.96e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.28e-06	1.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.27e-06	1.95e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.27e-06	1.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	2.26e-06	1.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—type 2 diabetes mellitus	2.26e-06	1.93e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.26e-06	1.93e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.25e-06	1.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.25e-06	1.92e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOB—type 2 diabetes mellitus	2.24e-06	1.92e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.23e-06	1.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.23e-06	1.91e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	2.22e-06	1.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	2.21e-06	1.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	2.19e-06	1.87e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	2.19e-06	1.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT2—type 2 diabetes mellitus	2.18e-06	1.87e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	2.18e-06	1.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—type 2 diabetes mellitus	2.18e-06	1.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.17e-06	1.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.17e-06	1.86e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LPL—type 2 diabetes mellitus	2.14e-06	1.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.12e-06	1.82e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	2.09e-06	1.79e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—type 2 diabetes mellitus	2.08e-06	1.78e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.08e-06	1.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	2.07e-06	1.78e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RELA—type 2 diabetes mellitus	2.04e-06	1.75e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CD36—type 2 diabetes mellitus	2.03e-06	1.74e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	2e-06	1.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—type 2 diabetes mellitus	1.98e-06	1.7e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	1.98e-06	1.7e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.98e-06	1.69e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—type 2 diabetes mellitus	1.98e-06	1.69e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.94e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.94e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.94e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.94e-06	1.66e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.93e-06	1.65e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	1.93e-06	1.65e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.92e-06	1.65e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.92e-06	1.64e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.92e-06	1.64e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.92e-06	1.64e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.91e-06	1.64e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.9e-06	1.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.9e-06	1.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—type 2 diabetes mellitus	1.89e-06	1.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.89e-06	1.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.89e-06	1.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.89e-06	1.62e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.89e-06	1.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.89e-06	1.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.88e-06	1.61e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.85e-06	1.58e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.84e-06	1.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.84e-06	1.58e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.83e-06	1.57e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.83e-06	1.56e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.82e-06	1.56e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1.8e-06	1.54e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.8e-06	1.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—type 2 diabetes mellitus	1.79e-06	1.53e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.78e-06	1.53e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.77e-06	1.52e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.76e-06	1.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.75e-06	1.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.74e-06	1.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	1.73e-06	1.48e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.73e-06	1.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.72e-06	1.48e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.72e-06	1.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.71e-06	1.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.71e-06	1.46e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.7e-06	1.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.7e-06	1.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.7e-06	1.45e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.68e-06	1.43e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—type 2 diabetes mellitus	1.67e-06	1.43e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.66e-06	1.42e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.66e-06	1.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.66e-06	1.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	1.66e-06	1.42e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.66e-06	1.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.65e-06	1.41e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.64e-06	1.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.61e-06	1.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SRC—type 2 diabetes mellitus	1.61e-06	1.37e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.59e-06	1.36e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.57e-06	1.35e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.56e-06	1.34e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.56e-06	1.34e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.56e-06	1.33e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.55e-06	1.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.54e-06	1.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—type 2 diabetes mellitus	1.54e-06	1.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—type 2 diabetes mellitus	1.53e-06	1.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.53e-06	1.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.53e-06	1.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—type 2 diabetes mellitus	1.53e-06	1.31e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.52e-06	1.3e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.51e-06	1.29e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.5e-06	1.28e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.48e-06	1.27e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.48e-06	1.27e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.47e-06	1.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.47e-06	1.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.47e-06	1.26e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.47e-06	1.26e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SRC—type 2 diabetes mellitus	1.46e-06	1.25e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.46e-06	1.25e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.45e-06	1.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.44e-06	1.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.41e-06	1.2e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—type 2 diabetes mellitus	1.34e-06	1.15e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	1.34e-06	1.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	1.31e-06	1.12e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.29e-06	1.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—type 2 diabetes mellitus	1.28e-06	1.1e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.28e-06	1.09e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.27e-06	1.08e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.27e-06	1.08e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	1.08e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.26e-06	1.08e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.25e-06	1.07e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.24e-06	1.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	1.23e-06	1.05e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.21e-06	1.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.18e-06	1.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.16e-06	9.91e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.15e-06	9.87e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.15e-06	9.83e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.13e-06	9.67e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.13e-06	9.63e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.11e-06	9.48e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.11e-06	9.48e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.1e-06	9.4e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.1e-06	9.4e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.1e-06	9.38e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-06	9.26e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—type 2 diabetes mellitus	1.08e-06	9.26e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.04e-06	8.89e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.02e-06	8.72e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	8.67e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1e-06	8.6e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.98e-07	8.54e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.87e-07	8.45e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—type 2 diabetes mellitus	9.87e-07	8.45e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	9.7e-07	8.31e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	9.67e-07	8.28e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	9.56e-07	8.18e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—type 2 diabetes mellitus	9.1e-07	7.79e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.42e-07	7.21e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	8.26e-07	7.07e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	7.62e-07	6.53e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.57e-07	6.48e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.24e-07	6.2e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.24e-07	6.2e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.62e-07	5.67e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—type 2 diabetes mellitus	6.17e-07	5.28e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.09e-07	4.36e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.05e-07	4.32e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.33e-07	2.85e-06	CbGpPWpGaD
